Delivery Order SPE2DB22D9239-SPE2DB23FDF10
Award Date 12/8/22
Potential Completion Date 12/30/22
Potential Value $136K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product EYLEA 2 MG/0.05 ML VIAL 0.05ML. The $134,355.50 delivery order was issued under an indefinite delivery contract held by DMS Pharmaceutical Group to supply medical and pharmaceutical items to DLA Troop Support Medical facilities worldwide. The order has a completion date of February 21, 2023. DMS Pharmaceutical Group...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA 2 MG/0.05 ML VIAL 0.05ML. This delivery order, valued at $5,253.92, has a completion date of February 1, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of pharmaceutical and medical products to support military treatment facilities worldwide through various DLA contracts and indefinite...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product EYLEA 2 MG/0.05 ML VIAL 0.05ML. This delivery order, valued at $134,355.50, was issued against an existing indefinite delivery contract between DMS Pharmaceutical Group and DLA to supply various medical supplies and pharmaceutical products to support military treatment facilities globally. The delivery order has a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,583.86 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the supply of EYLEA 2MG/0.05ML SY 1S, a pharmaceutical product. This delivery order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract with the DLA, valued at up to $4,999,999 through 2025, which enables the agency to order a broad range of pharmaceutical items to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product EYLEA 2 MG/0.05 ML VIAL 0.05ML. The contract has a potential value of $3,940.44 and a completion date of February 2, 2024. This delivery order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA to supply a variety of pharmaceutical and...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of EYLEA 2 MG/0.05 ML SYRINGE 0.05ML pharmaceutical products. This award, valued at $120,714.60, has a completion date of April 17, 2023. DMS Pharmaceutical Group holds various federal contracts and indefinite delivery vehicles (IDVs) to provide a range of pharmaceutical and medical supplies to support military treatment facilities...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $40,512 by the Defense Logistics Agency Troop Support Medical to provide 4563010385 EYLEA 2 MG/0.05 ML VIAL 0.05ML. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical products with a potential value of up to $5 million through December 2025. As a woman-owned small business and leading...
- The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Eylea 2 mg/0.05 ml vials. The order has a potential value of $130,638.72 and a completion date of September 14, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and Indefinite Delivery Vehicles (IDVs) to supply pharmaceuticals and medical products to support military treatment facilities...
- The Defense Logistics Agency awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the drug EYLEA 2 MG/0.05 ML VIAL 0.05ML. The potential value of the contract is $134,355.50 with a completion date of March 21, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal government, primarily the Department...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order (SPE2DX15D9114|SPE2DX25F5ZHY) valued at $25,838.60 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA 2 MG/0.05 ML syringes. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) under the SPE2DB program, which enables the DLA to issue firm fixed-price orders for a wide range of pharmaceutical products to support the medical supply needs of military...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB23FDF10Delivery Order
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA 2 MG/0.05 ML VIAL 0.05ML. This delivery order, valued at $135,794.00, is issued against an existing indefinite-delivery contract held by DMS Pharmaceutical Group to supply pharmaceuticals and medical supplies to military treatment facilities worldwide. The contract does not have a set-aside designation. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that supports the Department of Defense with a variety of brand-name and generic prescription and over-the-counter drug products.
Generated 3/22/24, 2:49 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $135.8k | 12/8/22 |